BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 36398557)

  • 1. [Application of adeno-associated virus-mediated gene therapy in lysosomal storage diseases].
    Lin XQ; Wang XL; Peng J
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Nov; 24(11):1281-1287. PubMed ID: 36398557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for the neurological manifestations in lysosomal storage disorders.
    Cheng SH
    J Lipid Res; 2014 Sep; 55(9):1827-38. PubMed ID: 24683200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for lysosomal storage disorders.
    Barranger JM; Novelli EA
    Expert Opin Biol Ther; 2001 Sep; 1(5):857-67. PubMed ID: 11728220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CNS-directed gene therapy for lysosomal storage diseases.
    Sands MS; Haskins ME
    Acta Paediatr; 2008 Apr; 97(457):22-7. PubMed ID: 18339183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in therapies for neurological lysosomal storage disorders.
    Ellison S; Parker H; Bigger B
    J Inherit Metab Dis; 2023 Sep; 46(5):874-905. PubMed ID: 37078180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for lysosomal storage disorders.
    Yew NS; Cheng SH
    Pediatr Endocrinol Rev; 2013 Nov; 11 Suppl 1():99-109. PubMed ID: 24380128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for lysosomal storage diseases (LSDs) in large animal models.
    Haskins M
    ILAR J; 2009; 50(2):112-21. PubMed ID: 19293456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on gene therapy for lysosomal storage disorders.
    Nagree MS; Scalia S; McKillop WM; Medin JA
    Expert Opin Biol Ther; 2019 Jul; 19(7):655-670. PubMed ID: 31056978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New strategies for the treatment of lysosomal storage diseases (review).
    Parenti G; Pignata C; Vajro P; Salerno M
    Int J Mol Med; 2013 Jan; 31(1):11-20. PubMed ID: 23165354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for lysosomal storage diseases: progress, challenges and future prospects.
    Seregin SS; Amalfitano A
    Curr Pharm Des; 2011; 17(24):2558-74. PubMed ID: 21774776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose Gene Therapy Reduces the Frequency of Enzyme Replacement Therapy in a Mouse Model of Lysosomal Storage Disease.
    Alliegro M; Ferla R; Nusco E; De Leonibus C; Settembre C; Auricchio A
    Mol Ther; 2016 Dec; 24(12):2054-2063. PubMed ID: 27658524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving therapies in neuronopathic LSDs: opportunities and challenges.
    Rajan DS; Escolar ML
    Metab Brain Dis; 2022 Oct; 37(7):2245-2256. PubMed ID: 35442005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the central nervous system in lysosomal storage diseases: Strategies to deliver therapeutics across the blood-brain barrier.
    Critchley BJ; Gaspar HB; Benedetti S
    Mol Ther; 2023 Mar; 31(3):657-675. PubMed ID: 36457248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of gene therapy in canine and feline models of lysosomal storage disorders.
    Bradbury AM; Gurda BL; Casal ML; Ponder KP; Vite CH; Haskins ME
    Hum Gene Ther Clin Dev; 2015 Mar; 26(1):27-37. PubMed ID: 25671613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in therapeutic approaches for lysosomal storage diseases.
    Urbanelli L; Magini A; Polchi A; Polidoro M; Emiliani C
    Recent Pat CNS Drug Discov; 2011 Jan; 6(1):1-19. PubMed ID: 21073432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy approaches for lysosomal storage disease: next-generation treatment.
    Byrne BJ; Falk DJ; Clément N; Mah CS
    Hum Gene Ther; 2012 Aug; 23(8):808-15. PubMed ID: 22794786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional correction of CNS phenotypes in a lysosomal storage disease model using adeno-associated virus type 4 vectors.
    Liu G; Martins I; Wemmie JA; Chiorini JA; Davidson BL
    J Neurosci; 2005 Oct; 25(41):9321-7. PubMed ID: 16221840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination Therapies for Lysosomal Storage Diseases: A Complex Answer to a Simple Problem.
    Macauley SL
    Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1(Suppl 1):639-48. PubMed ID: 27491211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy progress and prospects: gene therapy of lysosomal storage disorders.
    Cheng SH; Smith AE
    Gene Ther; 2003 Aug; 10(16):1275-81. PubMed ID: 12883523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic Stem Cell Gene Therapy for Storage Disease: Current and New Indications.
    Biffi A
    Mol Ther; 2017 May; 25(5):1155-1162. PubMed ID: 28389320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.